ConductScience.org, home

Paper39201414

Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.

Jannati S and 2 others. Int J Mol Sci, 2024. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling. Papers, record 39201414. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201414

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
6.27, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jannati SShirin
2Patnaik RRajashreehttps://orcid.org/0000-0003-2654-7007
3Banerjee YYajnavalkahttps://orcid.org/0000-0002-7546-8893

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InflammationMajor topic
AnticoagulantsMajor topic
Receptors, Proteinase-ActivatedMajor topic
Signal TransductionMajor topic
Humans
Administration, Oral
Animals
Rivaroxaban
Pyridones

Source PubMed

Download CSV of topics

References304

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136769872Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain.J Clin Med2023https://conductscience.org/library/papers/36769872PubMed
234639073Molecular Mechanism of the Anti-Inflammatory Action of Heparin.Int J Mol Sci2021https://conductscience.org/library/papers/34639073PubMed
315748242In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.J Thromb Haemost2005https://conductscience.org/library/papers/15748242PubMed
424449213Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.Blood2014https://conductscience.org/library/papers/24449213PubMed
527476789Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.Lancet Haematol2016https://conductscience.org/library/papers/27476789PubMed
622262775Asthma and coagulation.Blood2012https://conductscience.org/library/papers/22262775PubMed
725573421Effects of age and sex on the single-dose pharmacokinetics and pharmacodynamics of apixaban.Clin Pharmacokinet2015https://conductscience.org/library/papers/25573421PubMed
828798139Impact of Non-Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective.Arterioscler Thromb Vasc Biol2017https://conductscience.org/library/papers/28798139PubMed
926749408Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa.Am J Cardiovasc Drugs2016https://conductscience.org/library/papers/26749408PubMed
1030431565Comparison of dabigatran and warfarin used in patients with non-valvular atrial fibrillation: Meta-analysis of random control trial.Medicine (Baltimore)2018https://conductscience.org/library/papers/30431565PubMed
1136927031Evolutionary-scale prediction of atomic-level protein structure with a language model.Science2023https://conductscience.org/library/papers/36927031PubMed
1224810388Edoxaban: a focused review of its clinical pharmacology.Eur Heart J2014https://conductscience.org/library/papers/24810388PubMed
1332793635Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban.Front Cardiovasc Med2020https://conductscience.org/library/papers/32793635PubMed
1432244492A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF.Int J Mol Sci2020https://conductscience.org/library/papers/32244492PubMed
1512176812Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts.Ann Rheum Dis2002https://conductscience.org/library/papers/12176812PubMed
1617205215Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.Clin Rheumatol2007https://conductscience.org/library/papers/17205215PubMed
1737980924
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.
Lancet Haematol2024https://conductscience.org/library/papers/37980924PubMed
1829269019Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.Eur J Pharmacol2018https://conductscience.org/library/papers/29269019PubMed
1922849826Activation of PAR(2) receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint.Br J Pharmacol2012https://conductscience.org/library/papers/22849826PubMed
2033204010Author Correction: Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction.Sci Rep2020https://conductscience.org/library/papers/33204010PubMed

See all 304 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42741326
Rivaroxaban suppresses factor Xa-Driven PAR-2-ERK inflammatory, catabolic, osteoclastogenic, and mitochondrial dysfunction signaling in osteoarthritis-relevant chondrocytes: a drug-repurposing strategy for joint inflammation.
Front Pharmacol2026https://conductscience.org/library/papers/42741326PubMed
42737430Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/42737430PubMed
42652063Physiological Lipid Palmitoylcarnitine Constrains Factor Xa Signalling Through PAR-2 to Attenuate ERK-Driven Inflammation and Preserve Mitochondrial Membrane Potential in Chondrocytes.Biomedicines2026https://conductscience.org/library/papers/42652063PubMed
42625919Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care.Front Neurol2026https://conductscience.org/library/papers/42625919PubMed
42529014Rivaroxaban plus antiplatelet therapy for coronary artery ectasia: 36-month outcomes and risk prediction from a retrospective cohort study.Front Cardiovasc Med2026https://conductscience.org/library/papers/42529014PubMed
42522843Engineering Host-Guest Interactions for Next-Generation Heparin Biosensors.Small2026https://conductscience.org/library/papers/42522843PubMed
42328643Real-world bleeding risk and molecular interaction profiles of direct oral anticoagulants: a comparative study integrating clinical outcomes and in silico docking.Front Pharmacol2026https://conductscience.org/library/papers/42328643PubMed
42105000Fondaparinux attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and inflammatory signaling via the TLR4/NLRP3 and NF-κB/IL-1β/MCP-1 pathways.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42105000PubMed
42022786Biochemical Alterations Related to Vascular Injury in Smokers: Evidence from Nitric Oxide, Malondialdehyde, Nicotinic Acetylcholine Receptors, and Cotinine.Vasc Health Risk Manag2026https://conductscience.org/library/papers/42022786PubMed
41721545Anticoagulants beyond coagulation: a narrative review of cardiovascular effects.Cardiovasc Res2026https://conductscience.org/library/papers/41721545PubMed
41262558Advances in Transdermal Drug Delivery Systems for Antithrombotic Therapy: A Systematic Review.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/41262558PubMed
41002416Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells.Cells2025https://conductscience.org/library/papers/41002416PubMed
40943351Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.Int J Mol Sci2025https://conductscience.org/library/papers/40943351PubMed
40699690The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699690PubMed
40648975Evaluation of CHA2DS2-VA Score and Systemic Inflammatory Indexes in Patients with Nonvalvular Atrial Fibrillation: A Case-Control Study.J Clin Med2025https://conductscience.org/library/papers/40648975PubMed
40564985Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.Int J Mol Sci2025https://conductscience.org/library/papers/40564985PubMed
40457264KCNK2-mediated regulation of MMP-2/9 by PlGF influences uterine artery function in pregnancy-induced hypertension.BMC Pregnancy Childbirth2025https://conductscience.org/library/papers/40457264PubMed
40430925Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery.Pharmaceutics2025https://conductscience.org/library/papers/40430925PubMed
40353064Lower CALLY index levels indicate higher poor functional outcome risk in acute ischemic stroke patients treated with endovascular thrombectomy.Front Aging Neurosci2025https://conductscience.org/library/papers/40353064PubMed
40243559Selective Modulation of PAR-2-Driven Inflammatory Pathways by Oleocanthal: Attenuation of TNF-α and Calcium Dysregulation in Colorectal Cancer Models.Int J Mol Sci2025https://conductscience.org/library/papers/40243559PubMed

See all 24 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F102159PubTator's text mininghttps://conductscience.org/library/genes/2159NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201414

GET https://conductscience.org/api/papers/v1/39201414/references?page=2